PAMU
KNSA icon

Pictet Asset Management (UK)’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Pictet Asset Management (UK)’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$46.5M Buy
3,334,905
+847,672
+34% +$12.9M 0.05% 360
2021
Q1 		$46M Buy
2,487,233
+435,907
+21% +$8.92M 0.06% 345
2020
Q4 		$36.2M Buy
+2,051,326
New +$36M 0.05% 370

Other funds holding KNSA

HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Pictet Asset Management (UK)'s KNSA Position: Q2 2021 in Review

Pictet Asset Management (UK) increased its Kiniksa Pharmaceuticals (KNSA) stake by 34% in Q2 2021, buying an estimated $12.9M and bringing the position to 3,334,905 shares worth $46.5M. The position accounts for 0.05% of the portfolio, ranked #360.

Pictet Asset Management (UK) first reported a position in KNSA in Q4 2020 and has held it in 3 quarters since. 102 funds tracked by Wall St. Rank hold KNSA as of Q2 2021.

  • Pictet Asset Management (UK) held 3,334,905 shares of Kiniksa Pharmaceuticals worth $46.5M as of Q2 2021.
  • Pictet Asset Management (UK) bought 847,672 Kiniksa Pharmaceuticals shares in Q2 2021, an estimated $12.9M.
  • Kiniksa Pharmaceuticals made up 0.05% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #360 holding.
  • Pictet Asset Management (UK) first reported a position in Kiniksa Pharmaceuticals in Q4 2020 and has held it in 3 quarters since.
  • 102 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.